Immune cell atlas of cholangiocarcinomas reveals distinct tumor microenvironments and associated prognoses

Immunotherapy has demonstrated a limited clinical efficacy in approximately 5% of cholangiocarcinoma. The main challenges for an effective immunotherapy response in cholangiocarcinoma arise from the tumor micr...

Source: Journal of Hematology and Oncology - March 28, 2022 Category: Hematology Authors: Tao Xia, Keyu Li, Nan Niu, Yingkuan Shao, Ding Ding, Dwayne L. Thomas, Hao Jing, Kenji Fujiwara, Haijie Hu, Arsen Osipov, Chunhui Yuan, Christopher L. Wolfgang, Elizabeth D. Thompson, Robert A. Anders, Jin He, Yiping Mou & hellip; Tags: Research Source Type: research